Literature DB >> 3722417

Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.

S H Ralston, M D Gardner, F J Dryburgh, R A Cowan, I T Boyle.   

Abstract

The relation between urinary sodium excretion (NaE) and renal tubular calcium reabsorption (TmCa/GFR) was assessed in patients with hypercalcaemia associated with malignancy and primary hyperparathyroidism. On acute saline loading of seven normally hydrated patients with primary hyperparathyroidism and five patients with malignancy, raised values of TmCa/GFR were reduced to normal in most cases, in association with increases in NaE. The reduction in TmCa/GFR, which occurred, may have been due to a reduction in proximal tubular calcium reabsorption associated with sodium: this would have obscured the effect of humorally mediated increases in distal tubular calcium reabsorption, which are stimulated either by parathyroid hormone or by a putative humoral mediator in hypercalcaemia of malignancy. In patients who were normally hydrated NaE and TmCa/GFR were not significantly correlated. When data were included from patients who were dehydrated and from those undergoing acute saline loading, significant inverse correlations between NaE and TmCa/GFR were observed both in primary hyperparathyroidism (r = -0.49; p less than 0.02) and malignancy (r = -0.60; p less than 0.001). In clinical practice changes in TmCa/GFR associated with sodium seem to be of minor importance under normal circumstances, but they become evident at the upper and lower extremes of urinary sodium excretion. In clinical studies of renal calcium handling urinary sodium excretion must also be assessed, as interpreting TmCa/GFR data is difficult in states of excessive sodium loading or depletion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722417      PMCID: PMC499979          DOI: 10.1136/jcp.39.6.641

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  EFFECT OF VARIATIONS IN SODIUM INTAKE ON CALCIUM EXCRETION IN NORMAL HUMANS.

Authors:  C R KLEEMAN; J BOHANNAN; D BERNSTEIN; S LING; M H MAXWELL
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

2.  Relation between serum and urinary calcium with particular reference to parathyroid activity.

Authors:  M Peacock; W G Robertson; B E Nordin
Journal:  Lancet       Date:  1969-02-22       Impact factor: 79.321

3.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

Authors:  A F Stewart; R Horst; L J Deftos; E C Cadman; R Lang; A E Broadus
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

Review 4.  The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza; E L Simpson; J W Jacobs; T J Martin
Journal:  N Engl J Med       Date:  1984-06-28       Impact factor: 91.245

5.  Rehydration in the treatment of severe hypercalcaemia.

Authors:  D J Hosking; A Cowley; C A Bucknall
Journal:  Q J Med       Date:  1981

6.  Predictive value of derived calcium figures based on the measurement of ionised calcium.

Authors:  M D Gardner; F J Dryburgh; J A Fyffe; A S Jenkins
Journal:  Ann Clin Biochem       Date:  1981-03       Impact factor: 2.057

7.  Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.

Authors:  S H Ralston; I Fogelman; M D Gardner; F J Dryburgh; R A Cowan; I T Boyle
Journal:  Clin Sci (Lond)       Date:  1984-02       Impact factor: 6.124

8.  Characterisation and use of an intragenic polymorphic marker for detection of carriers of haemophilia B (factor IX deficiency).

Authors:  F Giannelli; D S Anson; K H Choo; D J Rees; P R Winship; N Ferrari; C R Rizza; G G Brownlee
Journal:  Lancet       Date:  1984-02-04       Impact factor: 79.321

9.  Mechanism of the hypocalcemic effect of mithramycin.

Authors:  D T Kiang; M K Loken; B J Kennedy
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

10.  Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.

Authors:  F J van Breukelen; O L Bijvoet; W B Frijlink; H P Sleeboom; H Mulder; A T van Oosterom
Journal:  Calcif Tissue Int       Date:  1982-07       Impact factor: 4.333

View more
  1 in total

Review 1.  Hypercalcemia of malignancy revisited.

Authors:  G R Mundy
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.